PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31
PURPLE BIOTECH LTD.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026
$1.08−0.06 (-5.26%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 40.0
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q4 FY2025 Ended Dec 31, 2025 | Mar 13, 2026 | Before market open | – | $0.10 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 10, 2025 | Before market open | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Mar 5, 2024 | Before market open | – | $0.19 | – |
| Q4 FY2022 Ended Dec 31, 2022 | Feb 8, 2023 | Before market open | – | – | – |
| Q4 FY2021 Ended Dec 31, 2021 | Feb 9, 2022 | Before market open | – | – | – |
Press releases
Announcements Purple Biotech filed with the SEC
PURPLE BIOTECH CORPORATE PRESENTATION AUGUST 2026
EX-99.1 to Form 6-K
PURPLE BIOTECH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
EX-99.1 to Form 6-K
VOTING SLIP FOR HOLDERS OF ORDINARY SHARES
EX-99.2 to Form 6-K
BNY MELLON VOTING INSTRUCTION FORM FOR HOLDERS OF AMERICAN DEPOSITARY SHARES
EX-99.3 to Form 6-K
PURPLE BIOTECH CORPORATE PRESENTATION JUNE 2026
EX-99.1 to Form 6-K
PURPLE BIOTECH ANNOUNCES NEW DATA FROM CAPTN-3 PLATFORM TRI-SPECIFIC IM1240
EX-99.1 to Form 6-K
PURPLE BIOTECH CORPORATE PRESENTATION MARCH 2026
EX-99.1 to Form 6-K
PURPLE BIOTECH REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
EX-99.1 to Form 6-K
PURPLE BIOTECH REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS
EX-99.1 to Form 6-K
PURPLE BIOTECH ANNOUNCES CEO TRANSITION
EX-99.2 to Form 6-K
PURPLE BIOTECH ANNOUNCES PLAN TO IMPLEMENT ADS RATIO CHANGE
EX-99.1 to Form 6-K
PURPLE BIOTECH CORPORATE PRESENTATION JANUARY 2026
EX-99.1 to Form 6-K
PURPLE BIOTECH CORPORATE PRESENTATION NOVEMBER 2025
EX-99.1 to Form 6-K
BNY MELLON VOTING INSTRUCTION FORM FOR HOLDERS OF AMERICAN DEPOSITARY SHARES
EX-99.2 to Form 6-K
PURPLE BIOTECH ANNOUNCES RECEIPT OF NASDAQ MINIMUM BID PRICE NOTIFICATION
EX-99.1 to Form 6-K
PURPLE BIOTECH CORPORATE PRESENTATION SEPTEMBER 2025
EX-99.1 to Form 6-K
PRESS RELEASE ISSUED BY PURPLE BIOTECH LTD. ON AUGUST 6, 2025
EX-99.1 to Form 6-K
Purple Biotech CEO Issues Letter to Shareholders
EX-99.1 to Form 6-K
PURPLE BIOTECH CORPORATE PRESENTATION JULY 2025
EX-99.1 to Form 6-K
PRESS RELEASE ISSUED BY PURPLE BIOTECH LTD. ON JUNE 23, 2025
EX-99.1 to Form 6-K
PRESS RELEASE ISSUED BY PURPLE BIOTECH LTD. ON JUNE 17, 2025
EX-99.1 to Form 6-K
PRESS RELEASE ISSUED BY PURPLE BIOTECH LTD. ON MAY 21, 2025
EX-99.1 to Form 6-K
PRESS RELEASE ISSUED BY PURPLE BIOTECH LTD. ON MAY 12, 2025
EX-99.1 to Form 6-K